There Ain’t No Such Thing as a Free Lunch (TANSTAAFL): Quality Costs Money

Wall Street has yet to grasp this essential truth of laboratory medicine-lab test quality comes with its own price tag At this moment in time, Quest Diagnostics Incorporated’s  (NYSE:DGX) advertised value proposition to other labs—”industry-leading quality and technical proficiency”—has diminished credibility with pathologists and lab industry executives. They are questioning how the nation’s largest lab company could allow systemic errors that caused it to report...

European LIS Competitor Eyes U.S. Market Via Lab Industry Survey

As healthcare becomes a global business, laboratory vendors from overseas are casting an envious eye on the market in the United States. After all, it is the world’s biggest and richest healthcare market, with more than $2 trillion in spending. Better yet, because healthcare in this country is organized around multiple payers and private providers, it provides competitive opportunities that don’t exist in many countries with single-payer health systems. Dark Daily has learned of a...
;